How should I conduct the physical exam and management for a 36-year-old patient with BMI 28.5, weight 80 kg, history of hyperlipidemia, chronic hepatitis B infection, hypertension, type 2 diabetes mellitus, and anxiety, who is not taking any medications and has no recent laboratory results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Management Priorities for This High-Risk, Untreated Patient

This 36-year-old patient with multiple untreated chronic conditions (diabetes, hypertension, hyperlipidemia, hepatitis B) requires urgent initiation of pharmacotherapy today—this is not a routine physical exam but a critical intervention visit to prevent imminent cardiovascular and hepatic complications.

Critical First Steps: Assessment and Risk Stratification

Physical Examination - Key Components

Focus your exam on these specific high-yield elements 1:

  • Blood pressure measurement (sitting, both arms) - expect hypertension given history
  • Weight, height, BMI calculation (already 28.5, overweight category)
  • Waist circumference - critical for metabolic risk; >94 cm in men or >88 cm in women indicates significantly increased morbidity risk 2
  • Comprehensive foot examination: visual inspection for skin integrity, pedal pulses for peripheral arterial disease, 10-g monofilament testing for neuropathy 1
  • Fundoscopic examination or immediate referral to ophthalmology for dilated eye exam 1
  • Skin examination: look for acanthosis nigricans (insulin resistance marker) 1
  • Thyroid palpation 1
  • Cardiovascular exam: assess for signs of heart failure or vascular disease

Mandatory Laboratory Testing Today

Order these labs immediately 1, 2:

  • HbA1c - to assess diabetes control (likely uncontrolled)
  • Fasting lipid panel: total cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C
  • Comprehensive metabolic panel: glucose, creatinine, eGFR, electrolytes, liver function tests
  • Spot urinary albumin-to-creatinine ratio - screen for diabetic nephropathy
  • Complete blood count with platelets
  • Hepatitis B panel: HBsAg, HBeAg, anti-HBe, HBV DNA quantitative, anti-HBc 3
  • Right upper quadrant ultrasound with alpha-fetoprotein - hepatocellular carcinoma surveillance for hepatitis B 3
  • TSH - screen for thyroid disease in diabetes 1

Critical Psychosocial Screening

Screen systematically for 1, 2:

  • Depression and anxiety symptoms (documented anxiety history)
  • Social determinants of health: food insecurity, housing stability, transportation access, financial barriers to medications
  • Medication rationing behaviors - why is this patient on NO medications despite multiple conditions?
  • Sleep patterns and obstructive sleep apnea risk (use STOP-BANG questionnaire given BMI 28.5) 2
  • Tobacco, alcohol, substance use 1

Immediate Treatment Initiation - Do Not Delay

Address the Medication Gap Urgently

This patient requires immediate pharmacotherapy for multiple life-threatening conditions. The fact that they're on no medications despite diabetes, hypertension, and hyperlipidemia represents a critical treatment failure.

Diabetes Management 1:

  • Start metformin immediately (unless contraindicated by renal function)
  • Set HbA1c goal based on today's results
  • Provide glucose meter and teach self-monitoring
  • Consider GLP-1 receptor agonist given overweight status and cardiovascular benefits

Hypertension Management:

  • Initiate ACE inhibitor or ARB (dual benefit for blood pressure and diabetic nephropathy protection) 1
  • Target blood pressure <130/80 mmHg 2
  • Monitor potassium after starting ACE inhibitor/ARB 1

Hyperlipidemia Management:

  • Start high-intensity statin therapy immediately given diabetes diagnosis (automatic high cardiovascular risk) 4, 5
  • Target aggressive LDL-C reduction

Hepatitis B Management 3:

  • Assess need for antiviral therapy based on HBV DNA, ALT levels, and liver fibrosis
  • If ALT elevated and HBV DNA >2,000 IU/mL, start nucleoside/nucleotide analogue
  • Initiate 6-month hepatocellular carcinoma surveillance protocol (ultrasound + AFP)

Anxiety Management:

  • Address psychiatric needs - untreated anxiety may be barrier to medication adherence
  • Consider SSRI if indicated

Obesity and Lifestyle Intervention

Use the "5 A's" framework 2:

  1. Ask permission: "Would it be alright if we discuss your weight and how it relates to your other health conditions?"

  2. Assess:

    • Obesity-related comorbidities (already present: diabetes, hypertension, hyperlipidemia)
    • Readiness to change
    • Barriers to weight loss

  3. Advise:

    • Explain obesity as chronic disease requiring long-term management
    • 5-10% weight loss significantly improves diabetes, blood pressure, lipids 2

  4. Agree on goals:

    • Initial weight loss target: 5-10% over 6 months
    • Dietary changes: reduced-calorie diet, consistent eating pattern
    • Physical activity: build toward ≥230 minutes moderate activity weekly 2
    • Daily self-weighing 2

  5. Arrange follow-up:

    • Refer to intensive behavioral weight management program
    • Consider GLP-1 agonist (dual benefit for diabetes and weight loss, achieving 8-21% weight loss) 2

Critical Safety Issues and Follow-Up

Hepatitis B Specific Concerns

  • Screen for cirrhosis using FibroScan or calculate Fibrosis-4 Index 2
  • Assess for metabolic dysfunction-associated steatotic liver disease (MASLD) - common with obesity, diabetes, hypertension 6, 7
  • Vaccinate close contacts for hepatitis B

Immediate Follow-Up Schedule

  • Return in 1-2 weeks to review labs and adjust medications
  • Monthly visits initially until all conditions controlled
  • Once stable: quarterly visits for diabetes management 1
  • Every 6 months: hepatocellular carcinoma surveillance, comprehensive foot exam 1, 3
  • Annual: dilated eye exam, comprehensive metabolic panel, lipid panel 1

Address Medication Adherence Barriers NOW

Investigate why patient takes no medications - this is the elephant in the room:

  • Financial barriers? Provide information on patient assistance programs
  • Health literacy issues? Simplify regimen, use teach-back method
  • Cultural beliefs? Address through motivational interviewing
  • Depression/anxiety interfering? Treat psychiatric conditions
  • Lack of access? Arrange care coordination, use mail-order pharmacy

The greatest immediate risk to this patient is continued non-treatment of multiple life-threatening conditions. Your primary goal today is initiating appropriate pharmacotherapy and ensuring adherence mechanisms are in place. This patient is at extremely high risk for myocardial infarction, stroke, diabetic complications, and hepatocellular carcinoma without immediate intervention 3, 5, 8.

References

3
Research

Hepatitis B: Part II. Updates on Diagnosis and Therapy.

American family physician, 2026

8
Research

Paradox of hepatitis B: Metabolic risk and cardiovascular protection in a national cohort.

International journal of cardiology. Cardiovascular risk and prevention, 2026

Related Questions

For a patient with total cholesterol 190 mg/dL, HDL 53 mg/dL, LDL 111 mg/dL, who is a non‑smoker, does not have diabetes, but has a history of hypertension, what is the appropriate lipid‑lowering management?
For a 55-year-old patient with a body mass index of 32.1, blood pressure of 110/54 mmHg, total cholesterol of 226 mg/dL, LDL cholesterol of 148 mg/dL, HDL cholesterol of 55 mg/dL, triglycerides of 133 mg/dL, and VLDL cholesterol of 23 mg/dL, how should I manage their hypercholesterolemia?
What is the appropriate management for a 31-year-old with total cholesterol 257 mg/dL, LDL 175 mg/dL, a history of hypertension, who does not smoke and does not have type 2 diabetes mellitus?
What is the recommended treatment for a 59-year-old male with hyperlipidemia (elevated Low-Density Lipoprotein (LDL) cholesterol), specifically an LDL level of 147, and a family history of hyperlipidemia?
How should I manage a 35-year-old patient with a body mass index of 32, blood pressure of 138/88 mmHg, total cholesterol of 232 mg/dL, HDL cholesterol of 34 mg/dL, triglycerides of 342 mg/dL, and LDL cholesterol of 125 mg/dL?
What is the clinical significance and recommended management for an asymptomatic adult with a direct bilirubin level of 0.3 mg/dL and otherwise normal liver function tests?
In an 89-year-old patient with dementia who was admitted and had sertraline resumed at the home dose of 100 mg at 16:45, should the dose be given now or delayed until the morning due to potential activation?
In a female patient with a hematocrit of 47.2% and a mean platelet volume of 11.2 fL, with otherwise normal laboratory results, what is the appropriate evaluation and management?
What is the appropriate management for a 28-year-old woman at 20 weeks gestation presenting to the emergency department with left flank pain, anorexia, and fever of 102 °F for two days?
For an adult, are the laboratory values red blood cell count (RBC) 3.77 ×10⁶/µL, hemoglobin 13 g/dL, hematocrit 37.7 %, and mean corpuscular hemoglobin (MCH) 34.5 pg normal, and is any further evaluation or treatment required?
Why do patients with lung fibrosis desaturate during exertion and take a long time to recover their oxygen saturation after stopping activity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.